Change - Announcement of Cessation::Resignation of Executive Director

Issuer & Securities

Issuer/ Manager
ARTIVISION TECHNOLOGIES LTD.
Securities
ARTIVISION TECHNOLOGIES LTD. - SG1X21941023 - 5NK
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
07-Sep-2017 17:29:21
Status
New
Announcement Sub Title
Resignation of Executive Director
Announcement Reference
SG170907OTHRN6GV
Submitted By (Co./ Ind. Name)
Harry Ng Weng Sui
Designation
Non-Executive Chairman and Independent Director
Description (Please provide a detailed description of the event in the box below)
RESIGNATION OF EXECUTIVE DIRECTOR

This announcement has been prepared
by the Company and its contents have
been reviewed by the Company's sponsor,
ZICO Capital Pte. Ltd. (the "Sponsor"), for
compliance with the Singapore Exchange
Securities Trading Limited ("SGX-ST") Listing
Manual Section B: Rules of Catalist. The
Sponsor has not independently verified the
contents of this announcement.

This announcement has not been examined
or approved by the SGX-ST and the SGX-ST
assumes no responsibility for the contents of
this announcement, including the correctness
of any of the statements or opinions made, or
reports contained in this announcement.

The contact person for the Sponsor is Ms.
Alice Ng, Director of Continuing Sponsorship,
ZICO Capital Pte. Ltd. at 8 Robinson Road,
#09-00 ASO Building, Singapore 048544, telephone (65) 6636 4201

Additional Details

Name Of Person
Ofer Miller
Age
47
Is effective date of cessation known?
Yes
If yes, please provide the date
07/09/2017
Detailed Reason (s) for cessation
Dr Miller has resigned as Executive Director and Chief Technology Officer of the Company following the completion of the Company's disposal of the entire issued and paid-up share capital of its wholly-owned subsidiary, Artimedia Pte. Ltd., to Dr Miller.

The Company's sponsor, ZICO Capital Pte. Ltd., after having interviewed Dr Miller, is satisfied that, other than as disclosed in this announcement, there are no material reasons for the resignation of Dr Miller as the Executive Director and Chief Technology Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
07/06/2004
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
8
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Technology Officer
Role and responsibilities
Spearheads the research and development efforts of the Group
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr Miller holds an aggregate of 15,111,244 ordinary shares in the capital of the Company.
Past (for the last 5 years)
None
Present
None